(Q38661579)

5 September 2017

title

Cellular and molecular mechanisms in graft-versus-host disease (English)

1 reference

5 September 2017

Lingling Zhang

1

1 reference

5 September 2017

Jianhong Chu

series ordinal

2

1 reference

5 September 2017

Jianhua Yu

series ordinal

3

1 reference

5 September 2017

Wei Wei

series ordinal

4

1 reference

5 September 2017

publication date

7 December 2015

1 reference

Journal of Leukocyte Biology

5 September 2017

published in

1 reference

5 September 2017

volume

99

1 reference

5 September 2017

issue

2

1 reference

5 September 2017

page(s)

279-287

1 reference

Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Treatment and management of graft-versus-host disease: improving response and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Current issues in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Current and emerging strategies for the prevention of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Advances in the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Targeting the IL17 pathway for the prevention of graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Novel role for surfactant protein A in gastrointestinal graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Immune cell subset counts associated with graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Dichotomous role of interferon-gamma in allogeneic bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Cytokines in Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Interleukin-17–Producing Cells Increase Among CD4+ Lymphocytes Before Overt Manifestation of Acute Graft-versus-Host Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

IL-17 contributes to CD4-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

T cells, murine chronic graft-versus-host disease and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

The role of regulatory T cells in the biology of graft versus host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Th17/Treg ratio in human graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Current data on IL-17 and Th17 cells and implications for graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Increased BCR responsiveness in B cells from patients with chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Intrinsic unresponsiveness of Mertk-/- B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Role of KIR3DS1 in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Natural killer cells and regulatory T cells in early pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

NK cell receptor NKp46 regulates graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

SOCS3 regulates graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Dendritic cell CD83: a therapeutic target or innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Blockade of individual Notch ligands and receptors controls graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

T cell-specific notch inhibition blocks graft-versus-host disease by inducing a hyporesponsive program in alloreactive CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.4RU0615-254RR

10.1189/JLB.4RU0615-254RR

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference